Comments
Loading...
Hepion Pharmaceuticals (HEPA) Forecast
NewsEarningsHepion Pharmaceuticals (HEPA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestHepion Pharmaceuticals (NASDAQ:HEPA) Stock Quotes, Forecast and News Summary
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Hepion Pharmaceuticals (HEPA) stock?
You can purchase shares of Hepion Pharmaceuticals (NASDAQ:HEPA) through any online brokerage.
Who are Hepion Pharmaceuticals (HEPA) competitors?
Other companies in Hepion Pharmaceuticals’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), cbdMD (AMEX:YCBD), Titan Pharma (NASDAQ:TTNP) and 60 Degrees (NASDAQ:SXTP).
What is the forecast, or price target, for Hepion Pharmaceuticals (HEPA) stock?
Hepion Pharmaceuticals has a consensus price target of $3.50.
What is the current price for Hepion Pharmaceuticals (HEPA)?
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $0.1281 last updated January 22, 2025 at 11:55 AM EST.
Does Hepion Pharmaceuticals (HEPA) pay a dividend?
There are no upcoming dividends for Hepion Pharmaceuticals.
When is Hepion Pharmaceuticals (NASDAQ:HEPA) reporting earnings?
Hepion Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, April 15, 2025.
Is Hepion Pharmaceuticals (HEPA) going to split?
There is no upcoming split for Hepion Pharmaceuticals.
What sector and industry does Hepion Pharmaceuticals (HEPA) operate in?
Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.